Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hiSCs for Rheumatoid Arthritis
NCT06947746Recruiting
- Sponsor
- Shanghai Changzheng Hospital
- Start
- May 2025
- Primary completion
- Jun 2026
- Countries
- 1
01
Overview
Open-label, single-arm trial in rheumatoid arthritis (RA), sponsored by Shanghai Changzheng Hospital. Primary endpoints: Treatment-Emergent Adverse Events and Serious Adverse Events at 12 weeks, Western Ontario and McMaster Universities Osteoarthritis Index at 24 weeks and 2 more. Started May 2025; status: recruiting.
02
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT06947746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06947746.